Antibiotic resistance: challenges and successes in respiratory infection
S Sethi, J Bryan - 2016 - Taylor & Francis
European Respiratory Society Congress, Amsterdam, 26–30 September 2015, and CHEST
2015, Montréal, Canada, 24–28 October 2015 With approximately 50,000 deaths in the US …
2015, Montréal, Canada, 24–28 October 2015 With approximately 50,000 deaths in the US …
Terapia inhalatoria en pacientes que reciben ventilación mecánica
F Íñiguez - Neumología Pediátrica, 2018 - neumologia-pediatrica.cl
Se discuten los factores que influyen en la terapia inhalatoria, tanto en general como
específicamente para pacientes ventilados, discutiendo los aspectos físicos, los …
específicamente para pacientes ventilados, discutiendo los aspectos físicos, los …
[HTML][HTML] Oral versus inhaled antibiotics for non‐cystic fibrosis bronchiectasis
S Spencer, LM Felix, SJ Milan… - The Cochrane …, 2017 - ncbi.nlm.nih.gov
Oral versus inhaled antibiotics for non‐cystic fibrosis bronchiectasis - PMC Back to Top Skip to
main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content …
main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content …
[PDF][PDF] Neumología Pediátrica
SCDEN PEDIÁTRICA - Chile: Dra. Solagne Caussade, 2018 - savalnet.cl
Neumología Pediátrica Órgano oficial de difusión de la Sociedad Chilena de Neumología
Pediátrica (SOCHINEP) y de la Sociedad Latinoamericana de Neumología Pediátrica (SOLANEP) …
Pediátrica (SOCHINEP) y de la Sociedad Latinoamericana de Neumología Pediátrica (SOLANEP) …
Routes of Antimicrobial Alternative Administration
MJ Cawley - 21st Century Challenges in Antimicrobial Therapy …, 2020 - books.google.com
Antimicrobial administration requires drug therapy to target the site of infection. Traditionally,
commercial oral and intravenous agents are the first route of administration for systemic …
commercial oral and intravenous agents are the first route of administration for systemic …
Aerosol antibiotic resistance gene dissemination among hospital departments by culture-facilitated comparative metagenomics
X Li, Z Wu, C Dang, M Zhang, B Zhao, Z Cheng… - 2020 - researchsquare.com
Background: Genes make microorganisms resistant to antibiotics are overwhelmingly
present in environments, and those in the air seem to consistently worsen human health …
present in environments, and those in the air seem to consistently worsen human health …
Clinical pharmacology of antibacterial drugs
MV Stolbova, IS Mitrofanova, TV Chernysheva… - 2020 - elibrary.ru
Making out adequate therapy with the help of modern antibacterial drugs helps in successful
and safe treatment of infectious diseases. Necessary information from textbook on …
and safe treatment of infectious diseases. Necessary information from textbook on …
7 profili klinicznych chorych z zakażeniami układu oddechowego, u których należy stosować azytromycynę
T Płusa - Alergoprofil, 2016 - journalsmededu.pl
Zakażenia układu oddechowego wciąż stanowią zagrożenie zdrowia i życia. Z tego powodu
nowe generacje antybiotyków powinny się cechować szerokim spektrum działania i …
nowe generacje antybiotyków powinny się cechować szerokim spektrum działania i …
Mukusinteraktion von Magnetit beladenen kolloidalen Wirkstoffträgern
C Thum - 2017 - publikationen.sulb.uni-saarland.de
Die pulmonale Wirkstoffapplikation gewinnt zunehmend an Bedeutung. Die Mukusbarriere,
eine der wichtigsten nicht-zellulären Barrieren, limitiert jedoch eine effiziente …
eine der wichtigsten nicht-zellulären Barrieren, limitiert jedoch eine effiziente …
[PDF][PDF] Inhaled antibiotics for ventilator-associated pneumonia: treatment or prophylaxis?
MI Restrepo - ers-education.org
Ventilator associated pneumonia (VAP) and Ventilator associated Tracheobronchitis (VAT)
are the most common infections in patients admitted to the ICU who required mechanical …
are the most common infections in patients admitted to the ICU who required mechanical …